IDEAS home Printed from https://ideas.repec.org/p/chy/respap/96cherp.html
   My bibliography  Save this paper

The importance of multimorbidity in explaining utilisation and costs across health and social care settings: evidence from South Somersets Symphony Project

Author

Listed:
  • Panos Kasteridis

    (Centre for Health Economics, University of York, UK)

  • Andrew Street

    (Centre for Health Economics, University of York, UK)

  • Matthew Dolman

    (Somerset Clinical Commissioning Group)

  • Lesley Gallier

    (South West Commissioning Support)

  • Kevin Hudson

    (South West Commissioning Support)

  • Jeremy Martin

    (The Symphony Project)

  • Ian Wyer

    (South Somerset Healthcare Federation)

Abstract

Aims - Since the inception of the NHS, an ever-present challenge has been to improve integration of care within the health care system and with social care. Many people have complex and ongoing care needs and require support from multiple agencies and various professionals. But care is often fragmented and uncoordinated, with no one agency taking overall responsibility, so it is often left to individuals and their families to negotiate the system as best they can. South Somersets Symphony is designed to establish greater collaboration between primary, community, acute and social care, particularly for people with complex conditions. Methods - We examine patterns of health and social care utilisation and costs for the local population to identify which groups of people would most benefit from better integrated care. We analyse data to identify groups of people according to the frequency of occurrence of underlying conditions; the cost of care; and utilisation of services across diverse settings. The empirical identification strategy is supplemented by local intelligence gained through workshops with health and social care professionals about the appropriateness of existing patterns of provision. We employ two-part regression models to explain variability in individual health and social costs, in total and in each setting. Data - The Symphony Project has an anonymised individual-level dataset, spanning primary, community, acute, mental health and social care. This includes activity, costs, clinical conditions, age, sex and ward of residence for the entire population of 114,874 people in 2012. Each persons morbidity profile is described using the United Health’s Episode Treatment Groups (ETG), which build upon ICD and Read codes. Results - We identify the frequency of conditions and co-morbidity profile of the entire population and, for the most frequent conditions, we assess utilization and costs of care across health and social care settings. For example, for those with asthma and diabetes, hospital costs account for the largest proportion of costs; in contrast, costs for those with dementia occur mostly in social care, mental health care and community care settings. For the population as a whole, we find that costs of health and social care are driven more by an individuals morbidity profile than by their age. Data for those with the most frequent conditions were reviewed by local health and social care professionals and managers. It was decided to undertake more detailed analyses for those with diabetes or dementia. 5,676 people are recorded as having diabetes in South Somerset, with hypertension being the most common comorbidity. For those with a sole diagnosis of diabetes, costs are around £1,000 on average but as people are recorded as having more diagnoses, average costs increase progressively. Costs are also higher for older people and women. People with dementia account for only 0.92% of the South Somerset population, but the average annual cost for the 1,062 people with dementia is around £12,000. A high proportion of these costs are related to the provision of mental health, social and continuing care. Costs are higher the more co-morbidities a person has, and for people from more deprived areas. Age and gender do not explain variation in costs for people with dementia. Conclusions - This work forms a basis for identifying groups that would most benefit from improved integrated care, which might be facilitated by integrated financial arrangements and better pathway management. The more co-morbidities that a person has, the more likely they are to require care across diverse settings, and the higher their costs. Our analysis identifies those groups of the population which are the highest users of services by activity and cost and provides baseline information to allow budgetary arrangements to be developed for these targeted groups.

Suggested Citation

  • Panos Kasteridis & Andrew Street & Matthew Dolman & Lesley Gallier & Kevin Hudson & Jeremy Martin & Ian Wyer, 2014. "The importance of multimorbidity in explaining utilisation and costs across health and social care settings: evidence from South Somersets Symphony Project," Working Papers 096cherp, Centre for Health Economics, University of York.
  • Handle: RePEc:chy:respap:96cherp
    as

    Download full text from publisher

    File URL: http://www.york.ac.uk/media/che/documents/papers/researchpapers/CHERP96_multimorbidity_utilisation_costs_health_social%20care.pdf
    File Function: First version, 2014
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Samuel L Brilleman & Hugh Gravelle & Sandra Hollinghurst & Sarah Purdy & Chris Salisbury & Frank Windmeijer, 2011. "Keep it Simple? Predicting Primary Health Care Costs with Measures of Morbidity and Multimorbidity," Working Papers 072cherp, Centre for Health Economics, University of York.
    2. Duan, Naihua, et al, 1983. "A Comparison of Alternative Models for the Demand for Medical Care," Journal of Business & Economic Statistics, American Statistical Association, vol. 1(2), pages 115-126, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Domenico Depalo, 2020. "Explaining the causal effect of adherence to medication on cholesterol through the marginal patient," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 110-126, October.
    2. Zhou, Wenhui & Zheng, Yanfang & Morton, Alec & Luo, Feng, 2018. "Delivering universal health coverage for an aging population: An analysis of the Chinese rural health insurance program," China Economic Review, Elsevier, vol. 52(C), pages 204-224.
    3. Pieter van Baal & David Meltzer & Werner Brouwer, 2016. "Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost‐Effectiveness Analysis," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 237-248, February.
    4. James Lomas & Miqdad Asaria & Laura Bojke & Chris P. Gale & Gerry Richardson & Simon Walker, 2018. "Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease," PharmacoEconomics - Open, Springer, vol. 2(4), pages 403-413, December.
    5. Mike Paulden & James O’Mahony & Anthony Culyer & Christopher McCabe, 2014. "Some Inconsistencies in NICE’s Consideration of Social Values," PharmacoEconomics, Springer, vol. 32(11), pages 1043-1053, November.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yang Lu, 2019. "Flexible (panel) regression models for bivariate count–continuous data with an insurance application," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 182(4), pages 1503-1521, October.
    2. Ed Westerhout & Kees Folmer, 2007. "Co-payment systems in health care; between moral hazard and risk reduction," CPB Discussion Paper 78.rdf, CPB Netherlands Bureau for Economic Policy Analysis.
    3. Silva João M. C. Santos & Tenreyro Silvana & Windmeijer Frank, 2015. "Testing Competing Models for Non-negative Data with Many Zeros," Journal of Econometric Methods, De Gruyter, vol. 4(1), pages 1-18, January.
    4. Tugba Akkaya Hocagil & Richard J. Cook & Sandra W. Jacobson & Joseph L. Jacobson & Louise M. Ryan, 2021. "Propensity score analysis for a semi‐continuous exposure variable: a study of gestational alcohol exposure and childhood cognition," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 184(4), pages 1390-1413, October.
    5. Ni, Xinwen, 2019. "Voting for Health Insurance Policy: the U.S. versus Europe," IRTG 1792 Discussion Papers 2019-012, Humboldt University of Berlin, International Research Training Group 1792 "High Dimensional Nonstationary Time Series".
    6. Buntin, Melinda Beeuwkes & Zaslavsky, Alan M., 2004. "Too much ado about two-part models and transformation?: Comparing methods of modeling Medicare expenditures," Journal of Health Economics, Elsevier, vol. 23(3), pages 525-542, May.
    7. Sandeep Rath & Kumar Rajaram, 2022. "Staff Planning for Hospitals with Implicit Cost Estimation and Stochastic Optimization," Production and Operations Management, Production and Operations Management Society, vol. 31(3), pages 1271-1289, March.
    8. Hsin‐Fan Chen & Sheng‐Hung Chen & Jie‐Min Lee & Huei‐Yann Jeng, 2010. "Who Are the Potential Smokers of Smuggled Cigarettes?," Asian Economic Journal, East Asian Economic Association, vol. 24(3), pages 221-234, September.
    9. Glenn W. Harrison & James P. Feehan & Alison C. Edwards & Jorge Segovia, 2003. "Cigarette Smoking and the Cost of Hospital and Physician Care," Canadian Public Policy, University of Toronto Press, vol. 29(1), pages 1-19, March.
    10. Liu, Jin-Long & Liu, Jin-Tan & Hammitt, James K. & Chou, Shin-Yi, 1999. "The price elasticity of opium in Taiwan, 1914-1942," Journal of Health Economics, Elsevier, vol. 18(6), pages 795-810, December.
    11. Deb, Partha & Trivedi, Pravin K., 2002. "The structure of demand for health care: latent class versus two-part models," Journal of Health Economics, Elsevier, vol. 21(4), pages 601-625, July.
    12. Gerko Vink & Laurence E. Frank & Jeroen Pannekoek & Stef Buuren, 2014. "Predictive mean matching imputation of semicontinuous variables," Statistica Neerlandica, Netherlands Society for Statistics and Operations Research, vol. 68(1), pages 61-90, February.
    13. Susan L. Ettner & Betsy L. Cadwell & Louise B. Russell & Arleen Brown & Andrew J. Karter & Monika Safford & Carol Mangione & Gloria Beckles & William H. Herman & Theodore J. Thompson & and The TRIAD S, 2009. "Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self‐care?," Health Economics, John Wiley & Sons, Ltd., vol. 18(6), pages 645-663, June.
    14. Massetti, Emanuele & Mendelsohn, Robert, 2017. "Do Temperature Thresholds Threaten American Farmland?," EIA: Climate Change: Economic Impacts and Adaptation 263482, Fondazione Eni Enrico Mattei (FEEM).
    15. Shuofen Hsu & Chaohsin Lin & Yaling Yang, 2008. "Integrating Neural Networks for Risk‐Adjustment Models," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 75(3), pages 617-642, September.
    16. Ulf‐ G. Gerdtham, 1997. "Equity in Health Care Utilization: Further Tests Based on Hurdle Models and Swedish Micro Data," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 303-319, May.
    17. Laszlo Goerke & Markus Pannenberg, 2005. "Severance Pay and the Shadow of the Law: Evidence for West Germany," Discussion Papers of DIW Berlin 541, DIW Berlin, German Institute for Economic Research.
    18. Michael Smart & Mark Stabile, 2005. "Tax credits, insurance, and the use of medical care," Canadian Journal of Economics, Canadian Economics Association, vol. 38(2), pages 345-365, May.
    19. Marion Kohler & Anthony Rossiter, 2005. "Property Owners in Australia: A Snapshot," RBA Research Discussion Papers rdp2005-03, Reserve Bank of Australia.
    20. Carole Roan Gresenz & Jeanette A. Rogowski & Jose Escarce, 2004. "Healthcare Markets, the Safety Net and Access to Care Among the Uninsured," NBER Working Papers 10799, National Bureau of Economic Research, Inc.

    More about this item

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:chy:respap:96cherp. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Gill Forder (email available below). General contact details of provider: https://edirc.repec.org/data/chyoruk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.